Navigation Links
The birth of biotech: San Francisco, Boston, Geneva or Chicago?

CHICAGO To start off our day, heres a pop biotech quiz to see if you know your biotech history and trivia:
  1. What were the first six biotech companies?
  2. How many of these companies still exist?
  3. How many of them are still completely independent?

While Im willing to bet that most of you will get at least three of the six companies right in the first question, ......

Full article >>> "http://www.wyeth.com">Wyeth.

Cetus, originally located in San Francisco and founded in the late 1970s as an innovative cancer therapy company, was acquired by Chiron in the early 1990s.

Amgen, which was originally known as Applied Molecular Genetics, was founded......

Full article >>> st monoclonal antibodies are produced.
  • 1977: The first expression of a human gene in bacteria.
  • 1978: Recombinant insulin is first produced.
  • 1979: Human growth hormone is first synthesized.
  • Also in the 1970s: RNA splicing, gene targeting, discovery of polymerases and of course the first commercial companies to develop genetically engineered products.
    During ......

    Full article >>> sity of Chicago.

    Goldwasser was born in 1922 (hes 82 today) in Brooklyn. After his family moved to Kansas City, he won a scholarship to University of Chicago and majored in biological sciences. During his initial time there, Goldwasser worked in the universitys toxicity lab on antidotes for chemical warfare agents (this was after the Japanese attack on Pearl Harbor).

    Upon graduat......

    Full article >>> o three dialysis patients with his small supply of EPO.

    His goal was to demonstrate an effect on patients with anemia of chronic renal disease. He also advised the University of Chicago and the government that he had a patentable invention. When he didnt hear back from these groups, he forgot about patenting his discovery.

    The results of his small Phase I were promising but incon......

    Full article >>> years later for $250 million). This helped the new company attract west coast VCs, which put up another $12 million. With this investment, the new company was off and running.

    Once funded, EPO became one of the lead projects and Salser invited Goldwasser to join the new Amgens scientific advisory board. Goldwasser preferred to work for Amgen as a consultant and Goldwasser provided Amgen ......

    Full article >>> wasser continued to investigate other aspects of EPO and focused on the kidney cells that produce EPO. While Amgen continued to support his lab at the rate of about $30,000 per year, the NIH lost interest in his work.

    As Goldwasser never patented any of his work, his financial share of Amgens successful sales of EPO never materialized.

    Still, he clearly was the pivotal person in ......

    Full article >>>
    '"/>


  • Source:wistechnology.com By Michael Rosen 08/25/04


    Related biology technology :

    1. The state of global biotech: An Ernst & Young perspective
    2. Health-care eyes focus on San Francisco, war of the stents
    3. Historic observatory becomes hot property on Lake Geneva
    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
    (Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
    (Date:1/19/2017)... NEW YORK , Jan. 18, 2017 /PRNewswire/ ... expected to reach USD 92.9 billion by 2025, ... Research, Inc. Pharmaceutical industry has been adaptive of ... functions as early as 2002. Among the services ... the forerunners. For instance, Johnson & Johnson was ...
    (Date:1/18/2017)... , January 18, 2017 According to a new market ... Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research ... to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, ... ... MarketsandMarkets Logo ...
    Breaking Biology Technology:
    (Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
    (Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
    (Date:12/15/2016)... 2016 Advancements in biometrics will ... and wellbeing (HWW), and security of vehicles ... passenger vehicles begin to feature fingerprint recognition, ... beat monitoring, brain wave monitoring, stress detection, ... pulse detection. These will be driven by ...
    Breaking Biology News(10 mins):